The results supported the need for identifying the risk group for OSA among express bus drivers and the need to diagnose them early for an early intervention.
To describe our experience in performing the lower cheek flap for access to the infratemporal fossa combined with the neurosurgical approach. Methods: Design: Case Report Setting: Tertiary Referral Center Patients: Two Result: Two unusual tumours involving the infratemporal and middle cranial fossa were excised using this combined approach. The infratemporal fossa tumour was accessed via the lower cheek flap while the intracranial portion was resected from above via craniotomy. Conclusion: The lower cheek flap in combination with the neurosurgical approach allows optimal exposure to tumours involving the infratemporal and middle cranial fossae. It has less complications and better aesthetic outcome compared to other approaches.
Objective: To describe our experience in managing two cases of primary malignant parotid
lymphoma.
Methods:
Design: Case Report
Setting: Tertiary University Referral Center
Patients: Two
Results: Both patients underwent superficial parotidectomy. Despite recurrence in one, the disease was controlled with conservative management. However, the disease was more aggressive in the other, requiring additional chemo-radiotherapy.
Conclusion: Malignant parotid lymphoma may present with varying stages, grades and clinical courses, requiring different management approaches. The treatment options are based on grading and staging at diagnosis and should be implemented depending on individual case.
Keywords: Parotid neoplasms, malignant lymphoma
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.